Serum carboxy-terminal telopeptide of type I collagen levels are associated with carotid atherosclerosis in patients with cardiovascular risk factors

Endocrine Journal
Takeshi KondoMasahiro Abe

Abstract

Carboxy-terminal telopeptide of type I collagen (ICTP) is generated through matrix metalloproteinase (MMP)-dependent type I collagen digestion, and has been widely utilized as a biomarker for bone turnover. The fact that atherosclerotic lesions are rich in both type I collagen and MMP-producing macrophages led to the hypothesis that serum ICTP concentrations may serve as a non-invasive clinical biomarker for atherosclerosis. Therefore, the association of serum ICTP concentrations with the maximum intima-media thickness (IMT) of carotid arteries, a surrogate index of systemic atherosclerosis, or brachial-ankle pulse wave velocity (baPWV) in patients with atherosclerotic risk factors was evaluated. A total of 52 male and 65 female (mean age: 62.8 yrs) patients without renal failure, malignancies or bone diseases known to affect serum ICTP concentrations were recruited. Patients with max IMTs ≥1.1 mm showed significantly higher serum ICTP concentrations compared with patients with max IMTs <1.1 mm (3.33 ± 0.97 vs 2.82 ± 0.65 ng/mL, p<0.05). Serum ICTP concentration was also positively correlated with max IMT (p<0.001) or baPWV values (p<0.05). Multivariate analyses also revealed that serum ICTP concentrations were correlated with ...Continue Reading

References

Sep 11, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C FornieriG Mori
May 23, 2002·American Journal of Hypertension·Michael F O'RourkeGérard E Plante
May 8, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P GarneroJ M Delaissé
Jan 13, 2006·Current Opinion in Lipidology·Johan Sundström, Ramachandran S Vasan
Feb 8, 2006·Circulation·Francesco U S Mattace-RasoJacqueline C M Witteman
May 5, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Joji IshikawaKazuyuki Shimada
May 1, 2010·Journal of the American College of Cardiology·Hirofumi TomiyamaAkira Yamashina
Aug 10, 2011·The American Journal of Cardiology·Ralph A DeFronzo, Muhammad Abdul-Ghani
Jun 9, 2012·BMJ : British Medical Journal·Meng LeeBruce Ovbiagele
Dec 18, 2013·Journal of Cardiovascular Medicine·Marco Matteo CicconeAnna Vittoria Mattioli
May 9, 2015·Arteriosclerosis, Thrombosis, and Vascular Biology·Isabel GoncalvesUNKNOWN SUMMIT Consortium

❮ Previous
Next ❯

Citations

Dec 12, 2018·American Journal of Physiology. Heart and Circulatory Physiology·Koen D Reesink, Bart Spronck
Aug 23, 2018·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J I BarzilayK J Mukamal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.